ArticleApplied health economics and health policy2022

Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers.

Renée E Michels et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.